O-2 '-Hydroxypropyltrimethyl ammonium chloride chitosan nanoparticles for the delivery of live Newcastle disease vaccine

文献类型： 外文期刊

第一作者： Dai, Chunxiao

作者： Dai, Chunxiao;Kang, Hong;Rong, Guangyu;Wang, Xiaohua;Wang, Xin;Zhao, Kai;Dai, Chunxiao;Cheng, Guogang;Jin, Zheng;Yang, Wanqiu;Sun, Jinyan;Liu, Chunlong

作者机构：

关键词： Nanoparticles;Chitosan derivatives;Newcastle disease;Mucosal immune delivery system;Sustained release

期刊名称：CARBOHYDRATE POLYMERS （ 影响因子：9.381； 五年影响因子：8.678 ）

ISSN：

年卷期：

页码：

收录情况： SCI

摘要： A novel complex chitosan derivative, O-2'-hydroxypropyltrimethyl ammonium chloride chitosan (O-2'-HACC), was synthesized and used to make nanoparticles as a delivery vehicle for live attenuated Newcastle disease vaccine. We found that O-2'-HACC had high antimicrobial activity, low toxicity, and a high safety level. Newcastle disease virus (NDV) was then encapsulated in the O-2'-HACC nanoparticles (NDV/La Sota-O-2'-HACC-NPs) by the ionic crosslinking method, and the properties of the resulting nanoparticles were determined by transmission electron microscopy, Zeta potential analysis, Fourier transform infrared spectroscopy, proton nuclear magnetic resonance spectroscopy, and X-ray diffraction. NDV/La Sota-O-2'-HACC-NPs had regular spherical morphologies and high stability, with an encapsulation efficiency of 95.68 +/- 2.2% and a loading capacity of 58.75 +/- 4.03%. An in vitro release assay indicated that release of NDV from NDV/La Sota-O-2'-HACC-NPs occurred slowly. Specific pathogen-free chickens immunized with NDV/La Sota-O-2'-HACC-NPs intranasally had much stronger cellular, humoral and mucosal immune responses than did those immunized intramuscularly or with live attenuated Newcastle disease vaccine. NDV/La Sota-O-2'-HACC-NPs are a novel drug delivery carrier with immense potential in medical applications. (C) 2015 Elsevier Ltd. All rights reserved.

分类号： O629`Q53

  • 相关文献

[1]Biological evaluation of N-2-hydroxypropyl trimethyl ammonium chloride chitosan as a carrier for the delivery of live Newcastle disease vaccine. Zhao, Kai,Wang, Xiaohua,Zhao, Kai,Sun, Yanwei,Chen, Gang,Rong, Guangyu,Kang, Hong,Wang, Xiaohua,Sun, Yanwei,Jin, Zheng.

[2]Utilization of Chitosan-Lactide Copolymer Nanoparticles as Controlled Release Pesticide Carrier for Pyraclostrobin Against Colletotrichum gossypii Southw. Huang, Qi-Liang,Xu, Lei,Cao, Li-Dong,Li, Feng-Min,Wang, Xiang-Jing.

[3]Enzymatic modification of chitosan by cinnamic acids: Antibacterial activity against Ralstonia solanacearum. Yang, Caifeng,Zhou, Yu,Zheng, Yu,Li, Changlong,Sheng, Sheng,Wang, Jun,Wu, Fuan,Yang, Caifeng,Zhou, Yu,Zheng, Yu,Li, Changlong,Sheng, Sheng,Wang, Jun,Wu, Fuan.

[4]Characterization and immunological evaluation of chitosan nanoparticles as adjuvants for bovine coronavirus N protein. Yu, Li,Sun, Qingshen,Zhang, Jialing,Han, Dequan,Yang, Yongbo,Zhu, Li. 2012

[5]Development and Evaluation of a pH-Dependent Sustained Release Tablet for Irritable Bowel Syndrome. Zhang, Shuang-Qing,Rahman, Ziyaur,Thumma, Sridhar,Repka, Michael A.,Zhang, Shuang-Qing,Li, San-Ming,Chen, Guo-Hua. 2009

[6]Size-Dependent Effect of Prochloraz-Loaded mPEG-PLGA Micro- and Nanoparticles. Zhang, Jiakun,Liu, Yajing,Cao, Lidong,Huang, Qiliang,Zhang, Jiakun,Zhao, Caiyan,Wu, Yan.

[7]The complete chloroplast genome of Tibetan hulless barley. Zeng, Quan Xing,Yuan, Jun Hong,Wang, Lin Yu,Xu, Jun Qi,Nyima, Tashi,Zeng, Quan Xing,Yuan, Jun Hong,Wang, Lin Yu,Xu, Jun Qi,Nyima, Tashi,Zeng, Quan Xing,Yuan, Jun Hong,Wang, Lin Yu,Xu, Jun Qi.

[8]Size-dependent effect of prochloraz-loaded mPEG-PLGA micro-and nanoparticles. Huang, Qiliang,Zhang, Jiakun,Cao, Lidong. 2014

[9]Genome-wide association study of antibody response to Newcastle disease virus in chicken. Luo, Chenglong,Qu, Hao,Ma, Jie,Wang, Jie,Li, Chunyu,Yang, Chunfen,Shu, Dingming,Hu, Xiaoxiang,Li, Ning,Luo, Chenglong,Qu, Hao,Ma, Jie,Wang, Jie,Li, Chunyu,Yang, Chunfen,Hu, Xiaoxiang,Shu, Dingming. 2013

[10]Enhancement of immune responses to Newcastle disease vaccine by a supplement of extract of Momordica cochinchinensis (Lour.) Spreng. seeds. Xiao, C.,Hu, S.,Xiao, C.,Bao, G.. 2009

[11]Expression analyses and antiviral properties of the Beijing-You and White Leghorn myxovirus resistance gene with different amino acids at position 631. Du, L. X.,Zhao, G. P.,Zhang, C. S..

[12]Enhancing Mucosal Immune Response of Newcastle Disease Virus DNA Vaccine Using N-2-Hydroxypropyl Trimethylammonium Chloride Chitosan and N,O-Carboxymethyl Chitosan Nanoparticles as Delivery Carrier. Zhao, Kai,Zhang, Yang,Wei, Lin,Yu, Shuang,Wang, Xiaohua,Han, Jinyu,Jin, Zheng,Wang, Yunfeng. 2018

[13]Synthesis, characterization, and immune efficacy of layered double hydroxide@SiO2 nanoparticles with shell-core structure as a delivery carrier for Newcastle disease virus DNA vaccine. Zhao, Kai,Rong, Guangyu,Guo, Chen,Luo, Xiaomei,Kang, Hong,Sun, Yanwei,Wang, Xiaohua,Wang, Xin,Sun, Qingshen,Rong, Guangyu,Sun, Yanwei,Cui, Shangjin,Dai, Chunxiao,Jin, Zheng. 2015

[14]Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration. Zhao, Kai,Li, Shanshan,Li, Wei,Yu, Lu,Duan, Xutong,Wang, Xiaohua,Zhao, Kai,Li, Shanshan,Yu, Lu,Duan, Xutong,Han, Jinyu,Jin, Zheng. 2017

[15]Rapid discrimination of H5 and H9 subtypes of avian influenza viruses and Newcastle disease virus by multiplex RT-PCR. Chen, Hao-tai,Zhang, Jie,Sun, De-hui,Zhang, Ji-le,Cai, Xue-peng,Liu, Xiang-tao,Ding, Yao-zhong,Ma, Li-na,Yang, Sheng-hai,Jin, Lei,Liu, Yongsheng. 2008

[16]Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease. Ge, Jinying,Wang, Xijun,Tian, Meijie,Wen, Zhiyuan,Feng, Qiulin,Qi, Xiaole,Gao, Honglei,Wang, Xiaomei,Bu, Zhigao. 2014

[17]Detection of Newcastle disease virus using nucleic acid sequence-based amplification. Cui, Shang-Jin,Fung, Yin-Wan Wendy,Lau, Lok Ting,Liu, Wen-Bin,Wang, Yun-Feng,Tong, Guang-Zhi,Chen, Jianguo,Yu, Albert Cheung Hoi. 2007

[18]Preparation and characterization of alpha-galactosidase-loaded chitosan nanoparticles for use in foods. Liu, Yong,Li, Yanli,Xu, Shaochun,Tang, Jiangwu,Xu, Yaoxing,Sun, Yan,Ding, Juntao. 2011

[19]Characteration of Protein Loaded Chitosan Nanoparticles at Different pH Values. Liu, Yong,Li, Yanli,Xu, Shaochun,Xu, Yaoxing,Sun, Yan. 2011

[20]Development of Ligand Incorporated Chitosan Nanoparticles for the Selective Delivery of 5-Fluorouracil to Colon. Li, Puwang,She, F. H.,Kong, L. X.,Li, Puwang,Li, Puwang,Peng, Zheng. 2011

作者其他论文 更多>>

微信小程序